IRIS
BONATI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.175
EU - Europa 1.722
AS - Asia 1.342
SA - Sud America 61
AF - Africa 30
OC - Oceania 6
Totale 5.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.124
CN - Cina 713
SG - Singapore 465
IE - Irlanda 315
IT - Italia 292
SE - Svezia 274
FI - Finlandia 242
UA - Ucraina 213
DE - Germania 196
TR - Turchia 103
NL - Olanda 89
BR - Brasile 56
CA - Canada 49
CI - Costa d'Avorio 27
RU - Federazione Russa 25
GB - Regno Unito 23
JP - Giappone 18
BE - Belgio 15
AT - Austria 14
IN - India 13
HK - Hong Kong 10
AU - Australia 5
CZ - Repubblica Ceca 5
AR - Argentina 4
EE - Estonia 4
ES - Italia 4
IR - Iran 4
KR - Corea 4
TW - Taiwan 3
BG - Bulgaria 2
ID - Indonesia 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
RO - Romania 2
CH - Svizzera 1
CO - Colombia 1
FR - Francia 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
Totale 5.336
Salva come PNG Salva come JPEG
Città #
Chandler 333
Jacksonville 322
Dublin 314
Singapore 258
Santa Clara 250
Beijing 189
Nanjing 113
Ann Arbor 105
Ashburn 99
Boardman 99
Parma 94
Izmir 91
Dearborn 87
Princeton 71
San Mateo 71
Jinan 47
Wilmington 47
Toronto 46
Hebei 41
Shenyang 39
Helsinki 31
Shanghai 31
Des Moines 30
Nanchang 29
Abidjan 27
Kunming 27
Bologna 25
Moscow 25
Hefei 20
Düsseldorf 18
New York 18
Tokyo 18
Woodbridge 17
Los Angeles 16
Brussels 15
Changsha 15
Tianjin 15
Guangzhou 13
Falls Church 12
Milan 12
Zhengzhou 12
Fremont 11
Grafing 11
Kocaeli 10
Nuremberg 10
Taizhou 10
Vienna 10
Haikou 9
Jiaxing 9
Leawood 9
Fuzhou 8
Hong Kong 8
Lanzhou 8
Modena 8
Seattle 8
Bremen 7
Falkenstein 7
Hangzhou 7
Redmond 7
Trezzano Sul Naviglio 7
Amsterdam 6
Borås 6
Chengdu 6
Houston 6
Munich 6
Taiyuan 6
Ningbo 5
Redwood City 5
Verona 5
Dallas 4
Langhirano 4
London 4
Mestre 4
Novara 4
Porto Alegre 4
Savignano Sul Rubicone 4
Auburn Hills 3
Bari 3
Bergamo 3
Chongqing 3
Council Bluffs 3
Mountain View 3
Piacenza 3
Pune 3
Reggio Nell'emilia 3
San Felice Sul Panaro 3
Suwon 3
São Paulo 3
Taipei 3
Xian 3
Ardabil 2
Arzano 2
Belo Horizonte 2
Brno 2
Cambridge 2
Casarsa della Delizia 2
Concórdia 2
Cremona 2
Fairfield 2
Focsani 2
Totale 3.447
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 227
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 145
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 112
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 93
Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role? 93
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication 92
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 86
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. 84
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells. 84
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 82
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 82
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 81
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 80
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 80
Su di un caso di sclerodermia associato ad aplasia midollare globale. 78
Ph1-positive acute myelocytic leukemia with high TdT levels. 78
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 78
Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia. 77
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 77
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 77
Emerging MEK inhibitors 76
T cell receptor genes: a glance at normal and malignant hematopoiesis. 76
p73 and p53 pathway in human breast cancers. 76
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 75
Human T-cell receptor alpha chain gene during ontogeny 75
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 74
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 74
Emerging Raf inhibitors 73
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 73
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 73
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 72
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. 72
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 71
Espressione degli antigeni CD1a, CD1b, CD1c in timo umano a diverse eta' dello sviluppo. 71
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. 71
null 69
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 69
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. 69
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes. 69
La mielofibrosi idiopatica asplenomegalica. Osservazioni cliniche e considerazioni su cinque casi. 69
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 68
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 67
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 66
The fine structure of HNK-1 (Leu7) positive cells. A study using an immunoperoxidase technique. 66
La linfoadenopatia angio-immunoblastica: Osservazioni cliniche, patologiche ed immunologiche su di un caso. 66
Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects. 66
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 65
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. 65
Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies. 62
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 61
Terminal deoxynucleotidyl transferase in human fetal tissues. 61
Valutazione dell'attivita proliferativa delle cellule emopoietiche nelle sindromi preleucemiche. 60
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 60
TCR beta chain expression during human thymic development. 60
Hemopoiesis during human fetal life. Present knowledge and future prospects. 59
Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival. 57
Targeting the cancer initiating cell: the ultimate target for cancer therapy. 57
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. 56
Terminal deoxynucleotidyl transferase (TdT) in human foetuses. An immunofluorescent and biochemical study. 56
Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues. 55
The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways 54
Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. 54
A micro-mechanically motivated model for the strength of heat-treated glass 54
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors. 53
Selective Expression and Constitutive Phosphorylation of SHC Proteins in the CD34+ Fraction of Chronic Myelogenous Leukemias. 52
Medicina molecolare: nuovi strumenti per la conoscenza e la cura delle patologie dell'uomo. 52
Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype. 52
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. 51
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 50
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 50
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. 49
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. 48
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. 46
Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. 43
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass 40
null 30
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 18
Totale 5.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 0 0 0 0 0 0 0 0 0 230 28 78
2020/2021499 2 70 37 3 82 17 35 13 111 19 101 9
2021/2022382 5 10 0 14 12 16 63 72 20 34 18 118
2022/20231.178 139 124 94 87 106 123 5 69 379 14 30 8
2023/2024407 33 47 17 8 55 68 24 9 15 23 34 74
2024/20251.192 60 92 105 60 212 201 38 76 227 121 0 0
Totale 5.362